Email it to Boustead. Maybe they didn't notice an announcement from (sigh) April 2020. That's such a long time ago, Yacov was still denying that they'd delist.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%